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ABSTRACT: A brief description of the magnetic resonance imaging and re-
lated advanced techniques like diffusion, perfusion and spectroscopy in the hu-
man brain examinations is given.
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1. INTRODUCTION
Magnetic resonance is an excellent physical technique for non-invasive de-
tection and anatomical mapping of water protons (H). The physical principles of 
magnetic resonance have been known since the 1940s [1,2], but the first imaging 
of the human body  with use of MRI was performed in the 1980s. Discovery of 
the MR phenomenon and, then, the development of the technology allowing ap-
plications of MR were awarded several Nobel prizes. 
In  1946 Felix  Bloch and Edward Purcell  independently  discovered MR  phe-
nomenon [1,2]  (Nobel Prize for Physics  1952). In 1971 Raymond Damadian 
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showed that the nuclear magnetic relaxation times of tissues and tumors dif-
fered, thus motivating scientists to consider MR for the detection of disease. In 
1975 Richard Ernst proposed MRI using phase and frequency encoding, and the 
Fourier Transform (Nobel Prize in Chemistry 1991). First imaging of the body 
using Ernst's technique was demonstrated in 1980 by Edelstein and coworkers. 
In 1977 Raymond Damadian demonstrated MRI called field-focusing NMR. In 
this same year, Peter Manseld developed the echo-planar imaging (EPI) tech-
nique, which in 1987 was used to perform real-time movie imaging of a single 
cardiac  cycle.  In  1987  Charles  Dumoulin  was  perfecting  MR  angiography 
(MRA), which allowed imaging of  flowing blood without the use of contrast 
agents. In 1992 functional MRI (fMRI) was developed. This technique allows 
the mapping of the function of the various regions of the human brain. In 2003 
Paul C. Lauterbur Sir Peter Manseld were awarded the Nobel Prize in Medicine 
for their discoveries concerning MRI.
D.MRI allows for structural and anatomical diagnosis in neuroradiology and 
since 1990s, together with advanced functional magnetic resonance techniques, 
like diffusion,  perfusion  and  spectroscopy,  provides  valuable  tools  in  human 
brain examinations.  In  this paper we give a short  description of  these tech-
niques.
2. MAGNETIC RESONANCE IMAGING
Currently, MRI is the most sensitive imaging test of the brain in routine clin-
ical  practice. Most  common  diagnoses  are:  cerebrovascular  accidents,  neo-
plasms, degenerative disease, demyelinating disease like multiple sclerosis,  in-
flammatory and infectious conditions,  developmental anomalies, hydrocephalus 
and brain abnormalities in patients with dementia. The differential diagnosis of 
tumoral (neoplastic) and pseudotumoral (mainly inflammatory and demyelinat-
ing) lesions represents an important step in patient assessment, influencing fur-
ther  management directions (for  details  see eg.  [3]-[9]).  Initially,  intracranial 
space-occupying lesions are typically classified as extra-  or intraaxial. Discrimi-
nation of extraaxial and intraaxial brain pathology is relatively easy: intraaxial 
means inside brain parenchyma, extraaxial lesions are of extracerebral location, 
arise from outside (Fig. 1).  They are usually benign. The location of brain tu-
mors affects treatment planning and predicts their prognosis. The most common 
intraaxial masses include primary neoplasms (high- and low-grade  gliomas), 
secondary  (metastatic)  neoplasms,  lymphoma,  tumefactive  demyelinating  le-
sions (TDLs), abscesses, and encephalitis. Most common extra-axial masses are 
meningiomas,  schwannomas,  arachnoid cysts, epidermoids, dermoids, chordo-
mas,  eosinophilic granulomas, pituary tumors.
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Fig. 1 Example of an extra-axial mass:
 meningioma, clearly outside brain parenchyma.
 Coronal T2WI.
The most common primary brain neoplasms are of glial origin, mainly astro-
cytomas. Low-grade (relatively benign)  glial  tumors  (LGG) occur most often 
in  patients  aged 20–40 years.  High-grade (aggresive,  malignant)  glial  lesions 
(HGG) occur  in older adults. Low-grade astrocytomas are  mostly of pilocytic 
(WHO I) and fibrillary (WHO II) type. High grade astrocytoma include anaplas-
tic (WHO III)  type  and  malignant glioblastoma multiforme (GBM) – WHO 
IV. GBM is the most frequent type (50% of all astrocytomas). Another impor-
tant glial tumors are oligodendrogliomas, also subdivided into low-  and high 
grades. Meningiomas are the most common non-glial primary CNS tumors and 
the most common extra-axial intracranial tumors.
The MRI image interpretation begins as locating and characterizing signal 
abnormalities. The alterations in signal intensity depend mostly on T1, T2 and 
proton density of the tissues and  technical parameters of pulse sequences. The 
higher the signal is, the brighter it will appear on the MR image.  Tissue charac-
terization includes analysis of  contrast for different signal weightings (Fig.2). 
Water and cerebrospinal fluid  with a long T1  and T2 relaxation times is dark in 
the T1-weighted image and bright in the T2-weighted image.  The content of 
cystic lesions can be isointense to CSF. Brain parenchyma is of intermediate sig-
nal, on T1WI gray matter is darker than white matter (anatomical pattern), on 
T2WI the reverse is true.  Gadolinium contrast agents reduce T1 and T2 times, 
resulting in an enhanced signal in the T1-weighted image. So - called conven-
tional  anatomic  MRI  imaging  includes  mostly  T1-weighted,  T2-weighted, 
FLAIR and contrast-enhanced T1-weighted images.   T1 is useful primarily as 
depiction of anatomy, T2 is very sensitive for pathology and FLAIR is basically 
M. Stachera, D. Strózik-Kotlorz, K. Sznajder
a T2-weighted image,  but fluid spaces are attenuated and appear dark. On con-
ventional imaging, most solid pathological lesions are hyperintensive   (bright) 
on  T2WI and hypointensive on T1WI sequences  due to a high water content. 
Very dense and hypercellular tumors with a low water content and a high nucle-
ar-cytoplasmasmic  ratio  like  CNS  lymphoma  and  PNET  appear  darker  on 
T2WI.  Similarily,   relatively high cellularity  and low water  content  of  most 
meningiomas may account for the usually isointense appearance on T1W im-
ages. On T2WI they are reported to be isointense to mildly hyperintense com-
pared with gray matter (Fig.2).
Fig. 2 Axial T2WI (upper left), FLAIR (upper right), T1WI (lower left),
 contrast-enhanced T1W (lower right) of typical meningioma. 
 Calcifications are mostly dark on T2WI. Other causes of low intensity on T2 
include blood degradation products (hemosiderin), protein, melanin, flow-void 
(loss of MRI signal caused by blood or CSF flow). 
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Most  lesions have a low or intermediate signal intensity on T1WI. Excep-
tions to this rule are methemoglobin, high protein or lipid content of cysts, fat 
and melanin. Some metastases, such as melanoma, are T1 hyperintense due to 
the paramagnetic effects of melanin. Hemorrhagic metastases may also demon-
strate T1 signal hyperintensity. Contrast enhancement represents disruption of 
the blood-brain barrier and is not specific.  However, post-contrast T1WI im-
prove both lesion detection (gadolinium contrast enhancement is vital to detect 
small metastases)  and differentiation. Typically nonenhancing lesions are: low-
grade neoplasms (LGG) and encephalitis. Typically enhancing lesions include 
abscesses,  lymphomas,  tumefactive demyelinating lesions (TDLs),  high-grade 
primary neoplasms (HGG) and metastatic lesions.  For peripherally enhancing 
masses, the main differential diagnosis lies between high-grade (HGG) and sec-
ondary  brain  tumours  (metastases),  inflammatory  or  demyelinating  lesions 
(TDL) and abscesses. Nearly all  meningiomas, neuromas and lymphomas en-
hance rapidly and intensely following contrast administration.
Fig.3 Glioblastoma multiforme. left: post-contrast T1WI image, right: T2WI.
 Central cystic area, enhancing part of the tumor and surrounding area of T2
 prolongation can be appreciated.
In  case  of  inhomogenous  lesions  (typical  example  is  glioblastoma  multi-
forme (Fig.3) it is important to analyse and describe all of the compartments: the 
enhancing components of the tumor, regions with peritumoral T2 prolongation 
and cystic areas within the tumor. The enhancing part of the tumor represents 
the viable tissue; cystic elements - central nonenhancing portion of ring-enhanc-
ing brain tumors represent necrosis. On gadolinium-enhanced T1WI solid part is 
M. Stachera, D. Strózik-Kotlorz, K. Sznajder
bright and cystic is variable. The surrounding area with peritumoral T2 prolon-
gation (bright on T2WI and FLAIR),  beyond the region of contrast enhance-
ment  represents vasogenic edema, but may also contain neoplastic infiltration. 
In case of gliomas it is not possible  to exactly delineate pure edema from tumor 
infiltration; precise tumor boundaries may not be evident on conventional MRI 
images. Metastases, on the other hand, tend not to infiltrate surrounding tissue. 
While interpretation of gadolinium-enhanced T1-weighted images,  T2-weighted 
and FLAIR images remains the mainstay of brain tumor and tumor-like lesion 
diagnosis, this approach has limitations. 
Conventional MR imaging frequently provides information that enable an ac-
curate  differential  diagnosis  between  tumoral  and  pseudotumoral  lesions  in 
roughly more than 50% of cases.  Imaging features include the number, topogra-
phy, and morphology of lesions, intrinsic lesion architecture and the pattern of 
contrast medium uptake.
Integration  of  diagnostic  information  from  advanced  MR  imaging  tech-
niques: diffusion, perfusion and spectroscopy can further improve the classifica-
tion accuracy of conventional anatomic imaging.
3. MR DIFFUSION-WEIGHTED AND PERFUSION IMAGING
Diffusion-weighted magnetic resonance imaging (DW MRI) allows non-in-
vasive mapping dependent on the molecular motion of water in biological tis-
sues in vivo. As this diffusion pattern can be substantially altered by disease, 
DW MRI has assumed an essential role in clinical practice, especially in neu-
roimaging. First DW MRI images were made public in 1985 [1] and became 
widespread in 1990s [2].
Thermal energy possessed by water molecules is expended as continual ran-
dom motion (Brownian motion), which can be quantitatively described by the 
self-diffusion coefficient (D). This water mobility is depend on its cellular envi-
ronment (Fig. 4) and can be considered anisotropic or isotropic, as it is predomi-
nantly unidirectional or not. Low cellularity of the tissue or cell membranes dis-
ruption reflects in greater movement of water molecules, while tumors, cytotox-
ic edema, abscess and fibrosis can be associated with impeded diffusion.
Diffusion weighted images (DWI) are made of voxels reflect rate of water 
diffusion at that location. As its sensitive to intravoxel diffusion directions het-
erogeneity, in case of tissue dominated by isotropic water movement diffusion 
spectrum imaging (DSI) is useful [3]. It allows for instance mapping of axonal 
trajectories.
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Fig. 4 Water molecule movement in different environment.
Initially DW sequence was described as adaptation of T2-weighted images 
[4]. Commonly used spin-echo T2-weighted sequence consist of a 90° RF pulse 
followed by a 180° RF pulse, with T2 decay related to transverse relaxation. In 
order to measure water diffusion, a dephasing gradient prior to the 180° and 
symmetric rephasing gradient after it must be applied. So called b value deter-
mines the sensitivity of DWI to process of diffusion.  Higher  b value mostly 
achieved by altering the gradient amplitude sequences are sensitive to even mi-
nor water displacement [5]. As DWI are also T2-weighted images, it is benefi-
cial to separate T2 relaxation and diffusion-related changes of the signal (for in-
stance from blood flow, perfusion, tissue pulsation). It is essential to calculate a 
ADC (apparent diffusion coefficient) maps. ADC is determined by the slope of 
the line plotted when the logarithm of relative signal intensity of tissue pointed 
along y-axis versus b value on the x-axis.
However DW MRI has been originally developed to imagine tumors of the 
liver, it quickly switched to stroke differential diagnosis (Fig.5). Nowadays DW 
MRI is commonly used for white matter disorders, especially in assessment of 
its tracts integrity in case of expansive lesions [6]. Within two past decades DW 
MRI has also been introduced for example in abdominal tumors detection and 
demarcation, differential diagnosis of cystic lesions and prostate cancer detec-
ting [7].
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Fig. 5 Axial diffusion-weighted image at b=500 (a) and b=2000 (b)
 in acute stroke of pons shows hyperintensive area in a brain stem.
This region demonstrates low signal intensity (restricted diffusion)
 on ADC map (c) obtained for the same patient.
Fig. 6 Relationship of perfusion parameters demonstrated
 on time-tracer concentration curve.
As a form of functional imaging MRI perfusion imaging (PWI) has become a 
clinical tool for evaluation of blood passage through the brain’s microvascular 
network. Use of rapid image acquisition methods allows non-invasive assess-
ment of various hemodynamic parameters such as cerebral blood flow (CBF), 
cerebral blood volume (CBV), mean transit time (MTT) and time to peak (TTP) 
[8] by measuring concentration of tracer agent whether exogenous (for example 
Gadolinium) or endogenous (spin labeling). During the first passage of Gadolin-
ium through cerebral circulation due to drop in the signal time-to-signal curve 
may be processed (Fig.6). This technique exploits the magnetic susceptibility ef-
fect of the tracer with T2 or T2* weighting in echo-planar imaging sequences. 
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The arterial spin labeling (ASL) technique uses the saturated blood witch up-
stream of the slice as a tracer.
Fig. 7  56-year-old woman with pontocerebellar angle tumor.
FLAIR image shows infratentorial hyperintense mass (a),
witch reveals high cerebral blood volume (b).
The flagship application of PWI in neuroimaging has been in assessment of 
stroke.  The  ischemic  brain  tissue  in  the  irreversibly  damaged  infarct  core 
presents decreased CBV and CBF as well as prolonged MTT. However so called 
‘mismatch’  between  diffusion  and  perfusion  abnormal  region  represents  is-
chemic penumbra, witch is surrounding viable ischemic tissue at risk that can 
take benefit from thrombolytic or neuroprotective therapy [9]. Furthermore anal-
ysis of PWI and DWI parameters facilitates differential diagnosis of brain tu-
mors like gliomas, metastases and lymphomas [10] (Fig.7). This techniques also 
enable to predict tumor response to antiangiogenic drugs and radiotherapy.
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4. MAGNETIC RESONANCE SPECTROSCOPY
MRS is apart from DWI and PWI an advanced technique of the functional 
magnetic  resonance imaging.  It  enables noninvasive chemical  analysis  of the 
brain, providing metabolic information. Several chemical elements can be used 
to obtain MRS of the brain but hydrogen is the most abundant atom in the hu-
man body.  Its nucleus emits  the most  intense signal in an external  magnetic 
field, in comparison to other nuclei, hence, hydrogen MRS is nowadays the most 
widely used method in neurospectroscopy. Together with MRI, DWI and PWI, 
MRS allows for the correlation of anatomical and physiological changes in the 
metabolic  and  biochemical  processes  occurring  within  given  volumes in  the 
brain.
There are two main techniques of proton MRS: single voxel and multivoxel. 
In SVS, a spectrum is obtained from a single sample selected volume (voxel), 
while in multivoxel MRS, called CSI, a much larger area can be covered, elimi-
nating the sampling error. Multivoxel technique allow the mapping of metabolic 
distribution in  a localized slice of the brain tissue. This can be helpful for differ-
ential  diagnosis  of  tumors  infiltrating  surrounding  tissue.  Multivoxel  spec-
troscopy is also used to assess response to therapy.
Basic principle of MRS is that protons in different molecules resonate at slightly 
different frequencies as a result of the local shielding by the electron cloud sur-
rounding the nucleus. In this way, in a proton spectrum at the external magnetic 
field of 1.5 T, the metabolites are spread out between 63 and 64 MHz or be-
tween 0 and 10 ppm, respectively. Each metabolite appears at a specific ppm 
value, and each one reflects specific cellular and biochemical processes.  Main 
metabolite peaks, visible in the brain spectra are NAA, Cr and Cho. NAA is a 
neuronal marker, Cr is a marker of energy storage and Cho is a marker of mem-
brane turnover. For more detailed characteristic of the brain metabolites see e.g. 
[20-24] and ref. therein. Analysis of the obtained spectra provides biochemical 
information of compounds present in brain tissues, being a powerful diagnostic 
tool in neuroradiology [25-30]. The common way to analyze clinical spectra is 
to determine metabolite ratios, e.g. NAA/Cr, Cho/Cr, Cho/NAA. In comparison 
to the adults, newborns have much less NAA and increased Cho and Ins, which 
is the glial cell marker. Prominent lactate peak is visible in the newborn spectra. 
Progression to the adult pattern follows myelination (Fig. 8).
DMRS analysis permits a safe and noninvasive examination of the brain tissue 
as different disease states have different MRS ‘‘signature’’. Hence MRS is use-
ful  in  differential  diagnosis  via  monitoring  biochemical  changes  in  tumors, 
stroke,  epilepsy,  metabolic disorders,  infections and neurodegenenerative dis-
eases (for review see eg. [25-30]). Specially,   MRS is very sensitive for detec-
ting brain tumors.
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Fig. 8 Comparison of the normal MR spectrum from the frontal lobe of the 
newborn (left) and the adult brain (right) at TE 30 ms. Description in the text.
Fig. 9 Comparison of the LGG (left) and HGG GBM (right) spectra.
Dominating lipid peak, denoting necrosis is visible in HGG MRS.
MRS can be helpful is determination of the  malignancy grade of the brain 
tumor. Low grade gliomas have elevated Cho and decreased Cr and NAA levels 
in comparison to the healthy tissue. High grade tumors typically have more ele-
vation of Cho and elevation of Lip and Lac as well.  As malignancy increases, 
NAA and Cr decrease, and Cho signal increases. The detection of lipids is typi-
cal  in  tissue necrosis for  the most  common HGG, GBM. Comparison of the 
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LGG and HGG spectra is shown in Fig. 9. MRS can also show abnormalities in-
visible on MRI. Namely, infiltrating gliomas, demonstrate elevated Cho beyond 
the  region  of  contrast  enhancement.  Using  this  pattern,  HGG can  be  distin-
guished from metastases or abscesses, which have normal Cho outside the re-
gion of enhancement. The most effective method to detect infiltration of malig-
nant cells beyond the enhancing margins of tumor is CSI. MRS can be also help-
ful in diagnosis non-glial tumors, like meningioma. Meningiomas are the most 
common non-glial  primary CNS tumors and the most common extra-axial in-
tracranial tumors (see Section 2). The common pattern found in meningioma is 
slightly elevated Cho and absent or very low NAA, which denotes non neuronal 
origin of mass. Cr is also very low or absent and variable amounts of Lac can be 
found. Most important is presence of inverted Ala peak at 1.5 ppm (Fig. 10). In 
mostly cases, meningioma can be clearly diagnosed from the MRI characteris-
tics, nevertheless MRS can confirm the diagnosis and moreover can be helpful 
in atypical cases of meningioma.
Fig. 10 Meningioma: MRI (left) and MRS (right). In MRS visible characteristic,
inverted at TE 135 ms triplet Ala-Lac signal at 1.3 – 1.5 ppm .
In  order to  optimally  distinguish between pathological and healthy tissue, 
one has to perform MRS examination both for tumor structure and reference 
normal area of the brain. Furthermore, MRS always requires correlation with the 
MRI and other functional imaging results before making a final reasonable neu-
rological diagnosis.
Magnetic resonance in human brain examinations. A brief outline of the techniques.
SUMMARY
We  gave  a  brief  characteristic  of  MRI  and  advanced  neuroimaging 
techniques.  The physical  principles  of  magnetic  resonance have been known 
since the 1940s but the first imaging of the human body  with use of MRI was 
performed in the 1980s. .MRI allows for structural and anatomical diagnosis in 
neuroradiology and since  1990s,  together  with advanced  functional  magnetic 
resonance  techniques,  like  diffusion,  perfusion  and  spectroscopy,  provides 
valuable  tools  in  human  brain  examinations.  The  MRI  image  interpretation 
begins as  locating and characterizing signal  abnormalities.  The alterations  in 
signal intensity depend mostly on T1, T2 and proton density of the tissues and 
technical parameters of pulse sequences. The higher the signal is, the brighter it 
will  appear  on  the  MR  image.  Tissue  characterization  includes  analysis  of 
contrast for different signal weightings. DW MRI allows non-invasive mapping 
dependent on the molecular motion of water in biological tissues in vivo. As this 
diffusion pattern can be substantially altered by disease, this technique  is very 
useful in clinical practice of neuroimaging. Another form of functional imaging 
is  PWI,  which  has  become  a  clinical  tool  for  evaluation  of  blood  passage 
through the brain’s microvascular network. The flagship application of PWI in 
neuroimaging is in assessment of stroke.  MRS allows a noninvasive chemical 
analysis of the brain using a standard high field MR system. The major peaks in 
the  spectrum  of  a  normal  brain  include  NAA,  Cr,  Cho  and  Ins,  which  are 
neuronal,  energetic,  membrane  turnover  and  glial  markers,  respectively.  In 
disease, two pathological metabolites can be found in the brain spectra: Lac, 
which is  end product of  anaerobic glycolysis  and Lip,  which is a  marker of 
membrane  breakdown,  occurring  in  necrosis.  Each  disease  state  has  its  own 
characteristic  spectroscopic  image.  MRS analysis  always  requires  correlation 
with  the  MRI  and  other  functional  imaging  results  before  making  a  final 
reasonable neurological diagnosis.
MRI and related advanced functional MR techniques, like DW MRI, PWI 
and MRS are nowadays a powerful tool in neuroradiology.
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